Cargando…

Glucagon receptor signaling regulates weight loss via central KLB receptor complexes

Glucagon regulates glucose and lipid metabolism and promotes weight loss. Thus, therapeutics stimulating glucagon receptor (GCGR) signaling are promising for obesity treatment; however, the underlying mechanism(s) have yet to be fully elucidated. We previously identified that hepatic GCGR signaling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nason, Shelly R., Antipenko, Jessica, Presedo, Natalie, Cunningham, Stephen E., Pierre, Tanya H., Kim, Teayoun, Paul, Jodi R., Holleman, Cassie, Young, Martin E., Gamble, Karen L., Finan, Brian, DiMarchi, Richard, Hunter, Chad S., Kharitonenkov, Alexei, Habegger, Kirk M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934938/ https://www.ncbi.nlm.nih.gov/pubmed/33411693 http://dx.doi.org/10.1172/jci.insight.141323

Ejemplares similares

OR28-5 Bile Acid Sequestration Accelerates Glucagon Receptor-Mediated Body Weight Loss in Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2019)

Hypothalamic Glucagon Receptors Regulate Feeding in Mice
por: Cunningham, Stephen E, et al.
Publicado: (2021)

SAT-655 Bile Acid Sequestration Synergistically Accelerates Glucagon Receptor-Stimulated Body Weight Loss in Diet-Induced Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2020)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)

Fibroblast activation protein (FAP) as a novel metabolic target
por: Sánchez-Garrido, Miguel Angel, et al.
Publicado: (2016)

Duodenal Endoluminal Barrier Sleeve Alters Gut Microbiota of ZDF rats
por: Kim, Teayoun, et al.
Publicado: (2016)

Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia
por: Rivero-Gutierrez, Belen, et al.
Publicado: (2018)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
por: Müller, Timo D., et al.
Publicado: (2020)

Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
por: Habegger, Kirk M., et al.
Publicado: (2013)

KLB, encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
por: Xu, Cheng, et al.
Publicado: (2017)

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

KLB dysregulation mediates disrupted muscle development in intrauterine growth restriction
por: Cortes‐Araya, Yennifer, et al.
Publicado: (2022)

Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
por: Jall, Sigrid, et al.
Publicado: (2017)

Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment
por: Girada, Shravan Babu, et al.
Publicado: (2017)

Glucagon Regulation of Energy Expenditure
por: Kleinert, Maximilian, et al.
Publicado: (2019)

Antiretroviral therapy potentiates high-fat diet induced obesity and glucose intolerance
por: Pepin, Mark E., et al.
Publicado: (2018)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese
por: Ji, Fang, et al.
Publicado: (2019)

Mito-Mendelian interactions alter in vivo glucose metabolism and insulin sensitivity in healthy mice
por: Sammy, Melissa J., et al.
Publicado: (2021)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
por: Knerr, Patrick J., et al.
Publicado: (2022)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

In utero nutritional stress as a cause of obesity: Altered relationship between body fat, leptin levels and caloric intake in offspring into adulthood
por: Sertie, Rogerio, et al.
Publicado: (2020)

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012)

The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation
por: Panera, Nadia, et al.
Publicado: (2021)

KLB and NOX4 expression levels as potential blood-based transcriptional biomarkers of physical activity in children
por: Galmés, Sebastià, et al.
Publicado: (2023)

Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
por: He, Rongjun, et al.
Publicado: (2019)

Both Acyl and Des-Acyl Ghrelin Regulate Adiposity and Glucose Metabolism via Central Nervous System Ghrelin Receptors
por: Heppner, Kristy M., et al.
Publicado: (2014)

Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
por: Lockie, Sarah H., et al.
Publicado: (2012)

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
por: Tiano, Joseph P., et al.
Publicado: (2015)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
por: Novikoff, Aaron, et al.
Publicado: (2021)

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
por: Sachs, Stephan, et al.
Publicado: (2023)

Branched Intermediate Formation Is the Slowest Step in the Protein Splicing Reaction of the Ala1 KlbA Intein from Methanococcus jannaschii
por: Saleh, Lana, et al.
Publicado: (2011)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

Glucagon and Its Receptors in the Mammalian Heart
por: Neumann, Joachim, et al.
Publicado: (2023)

Tail engagement of arrestin at the glucagon receptor
por: Chen, Kun, et al.
Publicado: (2023)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q396lp13nvg1info9k9tubdl8b